Olinvacimab Biosimilar – Anti-KDR, VEGFR2 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1-kappa-lambda

Brand

Product type

Clonality

Expression system

Applications

,

Product nameOlinvacimab Biosimilar - Anti-KDR, VEGFR2 mAb - Research Grade
SourceCAS 2095504-49-5
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsOlinvacimab,SSS-23,TTAC-0001,tanibirumab,KDR, VEGFR2,anti-KDR, VEGFR2
ReferencePX-TA1520
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa-lambda
ClonalityMonoclonal Antibody

Olinvacimab Biosimilar - Anti-KDR, VEGFR2 mAb binds to Human VEGFR2 Recombinant Protein in indirect ELISA Assay

Immobilized Human VEGFR2 Recombinant Protein (cat. No.PX-P3059) at 0.5µg/mL (100µL/well) can bind to Olinvacimab Biosimilar - Anti-KDR, VEGFR2 mAb (cat. No.PX-TA1520) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Olinvacimab Biosimilar – Anti-KDR, VEGFR2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products